Phase II ENZA-p Trial Explores Effect of Lutetium PSMA With Enzalutamide - Louise Emmett
https://www.urotoday.com/video-lectures/asco-gu-2025/video/4660-phase-ii-enza-p-trial-explores-effect-of-lutetium-psma-with-enzalutamide-louise-emmett.html
The results in combination with Enzalutamide is showing promising results, the best in the class
Clarity took the direction towards Enzalutamide is perfect, its going to be the "The BEST" given the safety profile being added and efficacy
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.13 |
Change
0.120(5.97%) |
Mkt cap ! $687.6M | |||
| Open | High | Low | Value | Volume |
| $2.09 | $2.16 | $2.04 | $4.243M | 2.013M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2553 | $2.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.14 | 4455 | 3 |
View Market Depth
| Last trade - 16.20pm 24/06/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |